Literature DB >> 28687839

Associations Between Vocal Symptoms and Genetic Variants in the Oxytocin Receptor and Arginine Vasopressin 1A Receptor Gene.

Sofia Holmqvist Jämsen1, Ada Johansson2, Lars Westberg3, Pekka Santtila1, Bettina von der Pahlen1, Susanna Simberg4.   

Abstract

Purpose: Oxytocin and arginine vasopressin are associated with different aspects of the stress response. As stress is regarded as a risk factor for vocal symptoms, we wanted to explore the association between the oxytocin receptor gene (OXTR) and arginine vasopressin 1A receptor gene (AVPR1A) single-nucleotide polymorphisms (SNPs) and vocal symptoms. We also wanted to explore whether such effects might be mediated by cortisol because oxytocin and vasopressin are associated with cortisol levels. Method: A population-based sample (N = 657) of Finnish twins (born 1961-1989) completed a web questionnaire on the occurrence of vocal symptoms. A total of 170 participants submitted saliva samples for hormone analysis. A total of 20 OXTR and AVPR1A SNPs were analyzed.
Results: Three OXTR polymorphisms (rs2270465, rs2268493, rs7632287) and 2 AVPR1A polymorphisms (rs1587097, rs1042615) showed nominal effects (p < .05) on vocal symptoms, of which 1 (rs1587097) remained significant after correcting for multiple testing (p = .003). We found potential mediation of the effect of the OXTR rs2268493 polymorphism on vocal symptoms through levels of cortisol. Conclusions: The associations between variants of OXTR and AVPR1A and vocal symptoms indicate that oxytocin and vasopressin might influence vocal symptoms. The effect of oxytocin seems to be partly mediated through cortisol actions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28687839     DOI: 10.1044/2016_JSLHR-S-16-0059

Source DB:  PubMed          Journal:  J Speech Lang Hear Res        ISSN: 1092-4388            Impact factor:   2.297


  1 in total

1.  AVPR1A main effect and OXTR-by-environment interplay in individual differences in depression level.

Authors:  A Kazantseva; Yu Davydova; R Enikeeva; M Lobaskova; R Mustafin; S Malykh; Z Takhirova; E Khusnutdinova
Journal:  Heliyon       Date:  2020-10-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.